On the origins of SARS-CoV-2 main protease inhibitors
Yves L. Janin
Abstract
inhibitors owe some of their origins to previous work on other proteases, we first provided a description of various inhibitors of cysteine-bearing human caspase-1 or cathepsin K, as well as inhibitors of serine proteases such as human dipeptidyl peptidase-4 or the hepatitis C protein complex NS3/4A. This is then followed by a description of the results of the approaches adopted (repurposing, structure-based and high throughput screening) to discover coronavirus main protease inhibitors.
Topics & Concepts
ProteasesProteaseRepurposingCysteine proteaseVirologyCathepsinNS3Protease inhibitor (pharmacology)Computational biologyBiologyChemistryEnzymeBiochemistryVirusEcologyViral loadAntiretroviral therapyComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchSynthesis and biological activity